WallStSmart
SLGC

Somalogic Inc

NASDAQ: SLGC · HEALTHCARE · HEALTH INFORMATION SERVICES

$9.90
+0.00% today

Updated 2026-05-28

Market cap
$396.23M
P/E ratio
P/S ratio
4.85x
EPS (TTM)
$-0.69
Dividend yield
52W range
$19 – $20
Volume
0.0M

Somalogic Inc (SLGC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20192020202120222023
Revenue$32.19M$55.89M$81.63M$97.67M$81.72M
Revenue growth (YoY)+73.6%+46.1%+19.7%-16.3%
Cost of revenue$49.72M$22.61M$33.46M$43.36M$48.09M
Gross profit$-17.53M$33.27M$48.16M$54.30M$33.63M
Gross margin-54.5%59.5%59.0%55.6%41.2%
R&D$32.50M$30.75M$43.50M$73.44M$57.93M
SG&A$33.32M$36.68M$77.27M$153.12M$128.24M
Operating income$-50.96M$-34.36M$-73.30M$-175.76M$-152.53M
Operating margin-158.3%-61.5%-89.8%-180.0%-186.6%
EBITDA$-47.80M$-31.53M$-86.00M$-175.76M
EBITDA margin-148.5%-56.4%-105.4%-180.0%0.0%
EBIT$-50.96M$-34.59M$-86.22M$-183.81M
Interest expense$0.00$18.34M$1.32M$109.25M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%
Net income$-57.00M$-71.35M$-86.30M$-109.16M$-130.38M
Net income growth (YoY)-25.2%-21.0%-26.5%-19.4%
Profit margin-177.1%-127.7%-105.7%-111.8%-159.5%

Frequently asked questions

What is Somalogic Inc's revenue?

Somalogic Inc's trailing twelve-month revenue is $81.72M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is SLGC?

In its most recent fiscal year, SLGC ran a gross margin of 41.15%, an operating margin of -186.64%, and a net margin of -159.54%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does SLGC generate?

SLGC produced $-121.89M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.